Immunogen Inc. buy JPMorgan Chase & Co.
Start price
13.09.23
/
50%
€15.24
Target price
13.09.24
€20.50
Performance (%)
90.15%
End price
14.09.24
-
Summary
This prediction is currently being closed. With a performance of 90.15% the BUY prediction by JPMorgan_Chase___Co_ is a big success. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Immunogen Inc. | - | - | - |
| iShares Core DAX® | 0,23 % | -2,41 % | 15,34 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % | 31,09 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % | 43,63 % |
| iShares S&P 500 | 1,07 % | -1,58 % | 24,35 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Immunogen Inc. diskutieren
ImmunoGen, Inc. (NASDAQ: IMGN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $22.00 price target on the stock, up previously from $9.00.
Ratings data for IMGN provided by MarketBeat
In the thread Trading Immunogen Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten